Clinical Trials Logo

Filter by:
NCT ID: NCT05230368 Recruiting - Clinical trials for HIV-1-infection, Subtype b

Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectable Viral Load

SYNACTHIV
Start date: December 14, 2022
Phase: Phase 1
Study type: Interventional

The ANRS 171 SYNACTHIV trial is an international multicenter pilot open label phase I trial. This trial will evaluate new procedures in LRA administration in 3 successive cohorts. In case of grade 3 to grade 5 adverse events, the inclusions and treatments will be (but not in a definitive manner) discontinued until the DSMB will conclude that the event was unrelated. Enrolment in cohort 2 then in cohort 3 will start only if no clinical grade 3 to grade 5 adverse event related to the LRAs occurs in the previous cohort.

NCT ID: NCT05230095 Completed - Parkinson Disease Clinical Trials

Social Cognition Dysfunctions in Parkinson's Disease

cognition 2
Start date: April 11, 2022
Phase:
Study type: Observational

Parkinson's disease (PD) is usually responsible of cognitive and behavioral non-motor signs with a major impact on the quality of life. Social cognition is a complex system relying on emotion recognition (neurons mirror system (NMS)), the theory of mind (with its two parts: emotional and cognitive), but also on the social and cultural environment and the personal history. The first step in this model is represented by the NMS, which seems to be altered in PD patients for both positive and negative emotions as shown in our preliminary study. The investigator purpose is to investigate the role of the treatment (levodopa and deep brain stimulation) on the functioning of the NMS

NCT ID: NCT05230043 Recruiting - Suicide, Attempted Clinical Trials

The Choice of a Violent Suicidal Means: a MRI Study With Computational Modeling of Decision-making

SUICIDE_DECIDE
Start date: March 21, 2022
Phase:
Study type: Observational

The study authors hypothesize a combination of cognitive, brain structural, brain functional and brain connectivity impairments in Suicide Attempters compared to Patient Controls and Healthy Controls, with deficits more marked in suicide attempters using violent suicidal means including: 1. Impaired choices at the reversal learning task with responses influenced by immediate outcome. This deficit would be correlated with brain activity in ventromedial Prefrontal Cortex during resting state and with several peripheral markers of the 5HT-system. 2. Reduced loss aversion. These deficits would be related to altered dynamics of Blood-Oxygen Level Dependent signal in the dorsal and ventral striatum as well as in ventral Prefrontal Cortex/ orbitofrontal cortex during the loss aversion task. These deficits would also be correlated with several peripheral markers of the 5HT-system. 3. Increased pain tolerance facilitating the execution of a violent and possibly painful act. These deficits measured with the algometer would be correlated with several peripheral markers of the 5HT-system. 4. Reduced behavioral inhibition in aversive context at the orthogonalized GoNoGo task facilitating the choice of a violent means. These deficits would be associated with altered Blood-Oxygen Level Dependent signal in ventral Prefrontal Cortex/ orbitofrontal cortex and parietal cortex during the resting state and correlated with several peripheral markers of the 5HT-system.

NCT ID: NCT05229939 Completed - Clinical trials for Kidney Transplantation

Estimating Glomerular Filtration Rate in Kidney Transplant Recipients

Start date: January 1, 2000
Phase:
Study type: Observational

Accurate estimation of the glomerular filtration rate (GFR) is crucial for the management of kidney recipients, since it is the most predictive parameter of allograft failure that drives patient monitoring and decision-making. Standard and recent race-free GFR equations have been developed in native kidneys, but their performances in transplant kidney population remains unknown. We aimed at developing a kidney-transplant-specific GFR equation, and comparing its performance to standard GFR equations.

NCT ID: NCT05229783 Recruiting - Barrett Esophagus Clinical Trials

High Resolution Virtual Chromoendoscopy Versus Seattle Protocol for the Surveillance of Barrett's Esophagus

CONVERSE
Start date: May 11, 2022
Phase: N/A
Study type: Interventional

The investigators hypothesize that careful examination of Barrett's esophagus by high-resolution endoscopy combined with virtual chromoendoscopy could replace the Seattle protocol for Barrett's esophagus monitoring and detection of dysplasic lesions, and thus modify existing recommendations.

NCT ID: NCT05229744 Recruiting - Clinical trials for Endolymphatic Hydrops

Prevalence of Endolymphatic Hydrops With a Hitory of Congenital Cytomegalovirus Infection

HYDROPS-CMV
Start date: December 15, 2022
Phase:
Study type: Observational

The management of patients with a history of congenital CMV infection (whether symptomatic or asymptomatic at birth) is modeled on their usual management.

NCT ID: NCT05229731 Withdrawn - Clinical trials for Visual Snow Syndrome

Description of the Neurovisual and Radiological Specificities of Patients With Visual Snow Syndrome

NEVICOG
Start date: April 13, 2022
Phase:
Study type: Observational

NEVICOG is a single-center study evaluating neurovisual and radiological specificities in patients with visual snow syndrome (VSS) compared to a control population.

NCT ID: NCT05229224 Recruiting - Clinical trials for Tension-Type Headache Episodic

Pilot Study of the Osteo-Fluidic-Sensitive (OFS) in Tension-type Headache.

Start date: November 29, 2022
Phase: N/A
Study type: Interventional

The hypothesis of the study is the Osteo-fluidic-Senstive is effective for lowering headache pains (Reduction of the number of days of headaches per month) for patients having frequent episodic tension-type headache. The OFS method will improve quality of life and will reduce the consumption of crisis treatments. Compare the efficacy of the Osteo-Fluidic-Sensitive method versus a placebo method on patients with tension type headache for the reduction of the number of days of headaches per month after 3 months of treatment at Centre Hospitalier Universitaire de Poitiers.

NCT ID: NCT05229159 Completed - Clinical trials for Post Operative Care After Cardiac Surgery With Cardio Pulmonary Bypass

Bio Impedance Electrical Analysis to Predict Outcome After Cardiac Surgery

BiPOCS
Start date: July 1, 2021
Phase:
Study type: Observational

Phase angle determined by bioelectrical impedance analysis is a strong prognostic factor in several medical areas as clinical nutrition, nephrology, infectious disease, oncology. Inflammation, frailty status and fluid overload can lead to a phase angle decreased. Some studies support its use for risk stratification in intensive care unit and other in preoperative for cardiac surgery. The investigators would like to evaluate its relevance for risk stratification at intensive care unit admission in the context of postoperative cardiac surgery with cardiopulmonary bypass.

NCT ID: NCT05228769 Active, not recruiting - Acquired Deafness Clinical Trials

Evaluation of the Quality of Life After a Multidisciplinary Auditory Rehabilitation Program

EQUAPRAP
Start date: December 1, 2021
Phase:
Study type: Observational

In 2008, the Handicap-Santé survey counted 10 million people with hearing difficulties in France, i.e. 16% of the national population. For 5.4 million of these people, the hearing limitations considered to be moderate to total, are likely to have repercussions on their daily life. In 2010, 600,000 people with hearing loss wore hearing aids, including 360,000 with very severe to total limitations who were unable to follow a conversation with others. Hearing loss can impact hearing skills (comprehension in noisy environments or with multiple speakers) and be a source of cognitive decline. It can also limit the quality of exchanges, communication and information taking. Several studies have shown that hearing loss can also have a negative effect on quality of life, psychological well-being, personal fulfillment, social relationships and can lead to social isolation, depression and/or anxiety. Currently, the treatment of people with hearing loss is often limited to hearing aids from a hearing aid specialist. Hearing rehabilitation and lip-reading training with a speech therapist may be offered at a later stage. However, many people who have been fitted with a hearing aid describe a decrease in their quality of life despite the fitting. Current treatment seems to deal mainly with auditory-cognitive problems. To date, no multidisciplinary rehabilitation services seem to be offered in France to take into account the other consequences of this condition: anxiety, depression, and limitations in social participation.